Accede al análisis completo con tu suscripción
Últimos 20 reportes · 10-K · 10-K/A · 10-Q · 8-K · Fuente: SEC EDGAR
Accede al análisis completo con tu suscripción
SEC CIK: 0001739940
The Cigna Group ® , together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company. At The Cigna Group our global workforce of approximately 67,700 colleagues strives to fulfill our mission to improve the health and vitality of more than 185 million customer relationships in more than 30 markets and jurisdictions (as of December 31, 2025). We play an important role in the health care system, and the breadth and depth of our customer relationships - as well as our approximately 1.7 million relationships with health care providers, clinics and facilities - give us opportunities to drive positive change. We have two segments: Evernorth Health Services ® and Cigna Healthcare ® . The Evernorth Health Services segment, through our Pharmacy Benefit Services and Specialty and Care Services operating segments, provides independent and coordinated health solutions and capabilities to enable the health care system to work better and help people live healthier lives.
Ver másConsenso de Analistas
Precio Objetivo — 12 meses
$290.00
Mínimo
+4.0%
$343.00
Mediana
+23.0%
$341.42
Promedio
+22.4%
$400.00
Máximo
+43.4%
| Métrica | LTM jun 26 | 2025 | 2024 | 2023 | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INGRESOS | |||||||||||
| Ingresos Totales | 282.382B | 274.900B | 247.121B | 195.265B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| PRIMAS Y COSTOS MÉDICOS (MLR) | |||||||||||
| Primas Devengadas | 38.040B | 40.261B | 45.996B | 44.237B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Costos Médicos | 32.456B | 34.349B | 38.648B | 36.287B | 🔒 | 🔒 | |||||
| GASTOS OPERATIVOS | |||||||||||
| Costo de Productos/Servicios | 224.128B | 214.991B | 182.509B | 133.801B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| SG&A / Operating Costs | 14.163B | 14.617B | 14.844B | 14.822B | 🔒 | 🔒 | |||||
| STOCK-BASED COMPENSATION | |||||||||||
| Stock-Based Compensation | 291.000M | 291.000M | 308.000M | 286.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| SBC / Revenue | 0.1% | 0.1% | 0.1% | 0.1% | 🔒 | 🔒 | |||||
| RESULTADO NETO | |||||||||||
| Pretax Income | 8.639B | 7.781B | 5.269B | 5.513B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Interest Expense (P&L) | 1.416B | — | — | — | 🔒 | 🔒 | |||||
| RESERVAS E INVENTARIO | |||||||||||
| Inventario Neto | 5.847B | 7.338B | 6.692B | 5.645B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| LIQUIDEZ E INVERSIONES | |||||||||||
| Cash & Equivalentes | 6.298B | 7.676B | 7.550B | 7.822B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Short-term Investments | 959.000M | 1.056B | 665.000M | 925.000M | 🔒 | 🔒 | |||||
| BALANCE — ACTIVOS | |||||||||||
| PP&E Neto | 3.651B | 3.651B | 3.654B | 3.695B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Goodwill | 45.534B | 44.924B | 44.370B | 44.259B | 🔒 | 🔒 | |||||
| CAPITAL Y DEUDA | |||||||||||
| Deuda Total | 31.878B | 31.463B | 31.972B | 30.930B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Net Debt | 24.621B | 22.731B | 23.757B | 22.183B | 🔒 | 🔒 | |||||
| FLUJO DE CAJA Y CAPEX | |||||||||||
| Cash Flow Operativo (CFO) | 10.277B | 9.601B | 10.363B | 11.813B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| NOPAT | 8.048B | 7.435B | 6.752B | 8.318B | 🔒 | 🔒 | |||||
| RATIOS | |||||||||||
| ROIC (NOPAT / IC) | 10.8% | 10.2% | 9.0% | 10.9% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| MLR (Benefit Ratio) | 85.3% | 85.3% | 84.0% | 82.0% | 🔒 | 🔒 | |||||
Cifras en miles de millones (B) · Fuente: SEC/EDGAR
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| MLR (Benefit Ratio) | 85.3% | 85.3% | 84.0% | 82.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Depreciación & Amort. | 2.724B | 2.775B | 2.775B | 3.035B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Income | 9.957B | 9.200B | 9.417B | 8.536B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Margin | 3.5% | 3.4% | 3.8% | 4.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Tax Expense | 1.656B | 1.493B | 1.491B | 141.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Beneficio Neto | 6.416B | 5.957B | 3.434B | 5.164B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Margen Neto | 2.3% | 2.2% | 1.4% | 2.6% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| EPS Diluido | 24.18 | 22.18 | 12.12 | 17.39 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| EPS Básico | 24.31 | 22.33 | 12.25 | 17.57 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Total Liquid Assets | 7.257B | 8.732B | 8.215B | 8.747B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Long-term Investments | 19.037B | 18.471B | 15.128B | 17.985B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Intangibles | 26.931B | 28.560B | 29.417B | 30.863B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Activo Total | 157.082B | 157.919B | 155.881B | 152.761B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Pasivo Total | 114.172B | 116.045B | 114.638B | 106.410B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Patrimonio Neto | 42.620B | 41.713B | 41.033B | 46.223B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Invested Capital | 74.498B | 73.091B | 75.079B | 76.460B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Acciones en Circulación | 264.240M | 263.464M | 273.789M | 292.504M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Recompras de acciones | 1.281B | 3.621B | 7.034B | 2.284B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Dividendos pagados | 1.624B | 1.611B | 1.567B | 1.450B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Dividendos por acción | 6.14 | 6.04 | 5.60 | 4.92 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Adquisiciones (Business) | 597.000M | 597.000M | 131.000M | 447.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| ROE (avg equity) | 15.2% | 14.4% | 7.9% | 11.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| ROA (avg assets) | 4.1% | 3.8% | 2.2% | 3.5% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Margin | 3.5% | 3.4% | 3.8% | 4.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Margen Neto | 2.3% | 2.2% | 1.4% | 2.6% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Effective Tax Rate | 19.2% | 19.2% | 28.3% | 2.6% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Debt / Equity Ratio | 0.75x | 0.75x | 0.78x | 0.67x | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
Precio actual · USD
$278.88
P/E LTM
11.53
Precio / EPS LTM diluido
ROIC (NOPAT / IC)
10.8%
NOPAT / (Equity + Debt)
MLR (Benefit Ratio)
85.3%
Costos médicos / Primas
ROE (avg equity)
15.2%
Benef. neto / Patrimonio
ROA (avg assets)
4.1%
Benef. neto / Activo total
Operating Margin
3.5%
Op. income / Ingresos
Margen Neto
2.3%
Benef. neto / Ingresos
Effective Tax Rate
19.2%
Tax / Pretax income